R. Morandini

818 total citations
24 papers, 694 citations indexed

About

R. Morandini is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, R. Morandini has authored 24 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cell Biology, 11 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in R. Morandini's work include melanin and skin pigmentation (12 papers), Cell Adhesion Molecules Research (4 papers) and Skin Protection and Aging (3 papers). R. Morandini is often cited by papers focused on melanin and skin pigmentation (12 papers), Cell Adhesion Molecules Research (4 papers) and Skin Protection and Aging (3 papers). R. Morandini collaborates with scholars based in Belgium, United Kingdom and Hungary. R. Morandini's co-authors include G. Ghanem, J.M. Boeynaems, Sheila MacNeil, Susan J. Hedley, John W. Haycock, T. J. de Vries, Erik H.J. Danen, D.J. Ruiter, S. Mac Neil and Paula C. Eves and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Annals of the New York Academy of Sciences.

In The Last Decade

R. Morandini

24 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Morandini Belgium 14 305 254 147 145 136 24 694
G. Ghanem Belgium 20 337 1.1× 407 1.6× 155 1.1× 205 1.4× 164 1.2× 44 913
Jonathan M. Eby United States 15 445 1.5× 203 0.8× 101 0.7× 175 1.2× 88 0.6× 32 796
Xi Luo China 11 215 0.7× 467 1.8× 136 0.9× 125 0.9× 53 0.4× 23 933
Han Na Suh South Korea 18 121 0.4× 489 1.9× 25 0.2× 145 1.0× 29 0.2× 46 835
H Senzaki Japan 15 89 0.3× 354 1.4× 142 1.0× 136 0.9× 46 0.3× 27 653
Kerstin Dehne Germany 11 105 0.3× 471 1.9× 15 0.1× 295 2.0× 36 0.3× 16 890
Claire Drullion France 10 141 0.5× 185 0.7× 46 0.3× 45 0.3× 15 0.1× 17 440
Melanie H. Smith United States 9 344 1.1× 519 2.0× 12 0.1× 143 1.0× 33 0.2× 16 1.0k
Sarah Kohn Israel 12 84 0.3× 309 1.2× 10 0.1× 108 0.7× 19 0.1× 20 647
Paul Holzfeind Austria 11 136 0.4× 621 2.4× 11 0.1× 43 0.3× 33 0.2× 13 819

Countries citing papers authored by R. Morandini

Since Specialization
Citations

This map shows the geographic impact of R. Morandini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Morandini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Morandini more than expected).

Fields of papers citing papers by R. Morandini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Morandini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Morandini. The network helps show where R. Morandini may publish in the future.

Co-authorship network of co-authors of R. Morandini

This figure shows the co-authorship network connecting the top 25 collaborators of R. Morandini. A scholar is included among the top collaborators of R. Morandini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Morandini. R. Morandini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wimana, Zéna, Géraldine Gebhart, Thomas Guiot, et al.. (2015). Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model. Molecular Imaging and Biology. 17(5). 697–703. 11 indexed citations
3.
Duez, Pierre, et al.. (2004). Cysteine but not Glutathione Modulates the Radiosensitivity of Human Melanoma Cells by Affecting Both Survival and DNA Damage. Pigment Cell Research. 17(3). 275–280. 27 indexed citations
4.
Eves, Paula C., John W. Haycock, Chris Layton, et al.. (2003). Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells. British Journal of Cancer. 89(10). 2004–2015. 57 indexed citations
5.
Morandini, R., et al.. (2001). TIPS AND STEP-BY-STEP PROTOCOL FOR THE OPTIMIZATION OF IMPORTANT FACTORS AFFECTING CELLULAR ENZYME-LINKED IMMUNOSORBENT ASSAY (CELISA). Journal of Immunoassay and Immunochemistry. 22(4). 299–321. 1 indexed citations
6.
Haycock, John W., et al.. (2000). α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines. Journal of Biological Chemistry. 275(21). 15629–15636. 77 indexed citations
7.
Hedley, Susan J., Andrew J. Murray, Karen Sisley, et al.. (2000). α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Research. 10(4). 323–330. 13 indexed citations
8.
Eves, Paula C., Chris Layton, Susan J. Hedley, et al.. (2000). Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin. British Journal of Dermatology. 142(2). 210–222. 58 indexed citations
9.
Morandini, R., et al.. (2000). The Degree of Pigmentation Modulates the Radiosensitivity of Human Melanoma Cells. Radiation Research. 154(5). 497–502. 28 indexed citations
10.
Haycock, John W., Manfred Wagner, R. Morandini, et al.. (1999). α‐MSH Immunomodulation Acts via Rel/NF‐κB in Cutaneous and Ocular Melanocytes and in Melanoma Cells. Annals of the New York Academy of Sciences. 885(1). 396–399. 21 indexed citations
11.
Morandini, R., J.M. Boeynaems, Susan J. Hedley, Sheila MacNeil, & G. Ghanem. (1998). Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. Journal of Cellular Physiology. 175(3). 276–282. 46 indexed citations
12.
Salès, François, et al.. (1998). α-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis. European Journal of Cancer. 34(3). 424–426. 7 indexed citations
13.
Süli‐Vargha, Helga, et al.. (1997). In Vitro Cytotoxic Effect of Difluoromethylornithine Increased Nonspecifically by Peptide Coupling. Journal of Pharmaceutical Sciences. 86(9). 997–1000. 1 indexed citations
14.
Danen, Erik H.J., et al.. (1996). E-cadherin expression in human melanoma. Melanoma Research. 6(2). 127–132. 85 indexed citations
15.
Morandini, R., et al.. (1996). Action of cAMP on expression and release of adhesion molecules in human endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 270(3). H807–H816. 59 indexed citations
16.
Morandini, R., et al.. (1994). Receptor‐mediated cyotoxicity of a‐MSH fragments containing melphalan in a human melanoma cell line. International Journal of Cancer. 56(1). 129–133. 20 indexed citations
17.
Süli‐Vargha, Helga, et al.. (1993). Receptor Binding and Cytotoxicity Studies with Melanotropin Fragments Containing Melphalan. Annals of the New York Academy of Sciences. 680(1). 616–618. 2 indexed citations
18.
Mármol, V. del, Shosuke Ito, Ian J. Jackson, et al.. (1993). TRP‐1 expression correlates with eumelanogenesis in human pigment cells in culture. FEBS Letters. 327(3). 307–310. 65 indexed citations
19.
Heimann, Pierre, et al.. (1993). Chromosomal findings in cultured melanocytes from a giant congenital nevus. Cancer Genetics and Cytogenetics. 68(1). 74–77. 7 indexed citations
20.
Ghanem, G., R. Morandini, Marco d’Ischia, et al.. (1992). Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents. Melanoma Research. 2(1). 25–32. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026